SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: BoredMember who wrote (10208)5/8/2018 3:57:13 PM
From: drkaz  Read Replies (1) | Respond to of 12873
 
And I am saying - your question is not relevant to anybody outside of the ownership of TheraCour, which is mostly Dr. Diwan.

I suspect that Dr. Diwan does 'care' about the future of NNVC. He has at least some prestige and a substantial amount of his reputation at stake if NNVC fails, and gains considerably in prestige, reputation and especially financially if NNVC succeeds in the end.

The relevant question is - has NNVC as an entity been a success? And to date the answer is fairly obviously a no. That could change. But not unless the points I make are accomplished.



To: BoredMember who wrote (10208)5/8/2018 7:45:26 PM
From: HardToFind  Respond to of 12873
 
If the question were does he care about the stock price or shareholders, that would be a different question.
If the world ever comes to believe he doesn't care about the shareholders or the stock price, his access to capital will be greatly diminished. Whether he does care or not, it is at least in his best interest to act like he cares.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News